Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$29.84 - $43.92 $23.4 Million - $34.4 Million
-783,469 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $21 Million - $32.5 Million
-701,621 Reduced 47.24%
783,469 $24.4 Million
Q3 2018

Nov 14, 2018

BUY
$40.12 - $45.55 $59.6 Million - $67.6 Million
1,485,090 New
1,485,090 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Select Equity Group, L.P. Portfolio

Follow Select Equity Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Select Equity Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Select Equity Group, L.P. with notifications on news.